Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Claudio Faria
Comparative Effectiveness of Early-Line Nab-Paclitaxel vs. Paclitaxel in Patients With Metastatic Breast Cancer: A US Community-Based Real-World Analysis
Cancer Management and Research
Oncology
Related publications
Quality-Adjusted Survival With Nab -Paclitaxel vs Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis
Clinical Breast Cancer
Cancer Research
Oncology
Nab-Paclitaxel for the Management of Triple-Negative Metastatic Breast Cancer
Anti-Cancer Drugs
Cancer Research
Oncology
Pharmacology
Role of Nab-Paclitaxel in Metastatic Breast Cancer: A Meta-Analysis of Randomized Clinical Trials
Oncotarget
Oncology
Cost-Effectiveness Analysis Comparing FOLFIRINOX and Nab-Paclitaxel (Abaraxane) Plus Gemcitabine for First-Line Treatment of Patients With Metastatic Pancreatic Cancer From the US Societal Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Comparative Effectiveness of Nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States
Advances in Therapy
Medicine
Pharmacology
Nab-Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer With Visceral Crisis: Evaluation of Efficacy and Tolerability in Clinical Practice
Medical Council
Tumor Reduction in Primary and Metastatic Pancreatic Cancer Lesions With Nab-Paclitaxel and Gemcitabine
Pancreas
Internal Medicine
Endocrinology
Hepatology
Metabolism
Diabetes
Oral Paclitaxel in the Treatment of Metastatic Breast Cancer (MBC) Patients.
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Paclitaxel in Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
